ReCAnt | Resource on Chemicals Used in Aquaculture and Their Ecotoxicity

Ciprofloxacin

Effects reported: Enzyme(s) Biochemistry Histology Accumulation Physiology

← Scroll →

ⓘ Table glossary

Reference	Experiment type	Cell / tissue	Test organism	Lifestage	Administration	Administered dose	Significant dose	Trend	Measurement	Effect
PMID:33382204	In vivo	-	Cirrhinus mrigala	Fingerling	-	1.0-1.5 µg/L	1.0-1.5 µg/L	Changed	Glutathione S-transferase activity	Enzyme(s)
	In vivo	-	Cirrhinus mrigala	Fingerling	-	1.0-1.5 µg/L	1.0-1.5 µg/L	Decreased	Catalase activity	Enzyme(s)
	In vivo	-	Cirrhinus mrigala	Fingerling	-	1.0-1.5 µg/L	1.0-1.5 µg/L	Decreased	Chloride	Biochemistry
	In vivo	-	Cirrhinus mrigala	Fingerling	-	1.0-1.5 µg/L	1.0-1.5 µg/L	Decreased	Potassium content	Biochemistry
	In vivo	-	Cirrhinus mrigala	Fingerling	-	1.0-1.5 µg/L	1.0-1.5 µg/L	Decreased	Sodium content	Biochemistry
	In vivo	-	Cirrhinus mrigala	Fingerling	-	1.5 µg/L	1.5 µg/L	Increased	Catalase activity	Enzyme(s)
	In vivo	-	Cirrhinus mrigala	Fingerling	-	1.0-1.5 µg/L	1.0-1.5 µg/L	Increased	Cytoplasmic vacuoles	Histology
	In vivo	-	Cirrhinus mrigala	Fingerling	-	1.0-1.5 µg/L	1.0-1.5 µg/L	Increased	Epithelial lifting in gills	Histology
	In vivo	-	Cirrhinus mrigala	Fingerling	-	1.0-1.5 µg/L	1.0-1.5 µg/L	Increased	Fatty infiltration in liver	Accumulation
	In vivo	-	Cirrhinus mrigala	Fingerling	-	1.0-1.5 µg/L	1.0-1.5 µg/L	Increased	Fragmented glomerulus in kidney	Histology
	In vivo	-	Cirrhinus mrigala	Fingerling	-	1.0-1.5 µg/L	1.0-1.5 µg/L	Increased	Hydropic swelling in liver	Histology
	In vivo	-	Cirrhinus mrigala	Fingerling	-	1.0-1.5 µg/L	1.0-1.5 µg/L	Increased	Hypertrophy in kidney	Histology
	In vivo	-	Cirrhinus mrigala	Fingerling	-	1.0-1.5 µg/L	1.0-1.5 µg/L	Increased	Lamellar fusion in gills	Histology
	In vivo	-	Cirrhinus mrigala	Fingerling	-	1.0-1.5 µg/L	1.0-1.5 µg/L	Increased	Lipid peroxidation	Physiology
	In vivo	-	Cirrhinus mrigala	Fingerling	-	1.0-1.5 µg/L	1.0-1.5 µg/L	Increased	Loosening of primary gill bar	Histology
	In vivo	-	Cirrhinus mrigala	Fingerling	-	1.0-1.5 µg/L	1.0-1.5 µg/L	Increased	Necrosis in gills	Histology
	In vivo	-	Cirrhinus mrigala	Fingerling	-	1.0-1.5 µg/L	1.0-1.5 µg/L	Increased	Necrosis in kidney	Histology
	In vivo	-	Cirrhinus mrigala	Fingerling	-	1.0-1.5 µg/L	1.0-1.5 µg/L	Increased	Nuclei degeneration in liver	Histology
	In vivo	-	Cirrhinus mrigala	Fingerling	-	1.0-1.5 µg/L	1.0-1.5 µg/L	Increased	Superoxide dismutase (SOD) enzyme activity	Enzyme(s)
	In vivo	-	Cirrhinus mrigala	Fingerling	-	1.0-1.5 µg/L	1.0-1.5 µg/L	Increased	Vacuolization in kidney	Histology
	In vivo	-	Cirrhinus mrigala	Fingerling	-	1.0-1.5 µg/L	1.0-1.5 µg/L	Increased	Vacuolization in liver	Histology

ⓘ

Glossary ×

ReferencePubMed ID of research paper

Experimental TypeIn vivo or in vitro

Cell / TissueIf in vitro, cells derived from aquaculture-relevant species

Cell / TissueIf in vitro, tissues obtained from aquaculture-relevant species

Cell / TissueIf in vivo, left blank

Test OrganismAquaculture-relevant species tested for toxic effect

LifestageLifestage of the test organism if mentioned in the reference

AdministrationRoute by which the chemical enters the test organism or treatment method

Administered dose rangeDifferent doses of chemicals tested in this study

Significant dose rangeSignificant result(s) at specific doses

Trend Direction of effect over time

Measurement Parameter used to quantify the effect

Effect Overall observed biological outcome or toxicological effect

Ciprofloxacin

DISCLAIMER